Abstract
Five patients with hepatic metastases of midgut carcinoid underwent somatostatin receptor scintigraphy with indium-111 pentetreotide before and during treatment with octreotide. Octreotide treatment changed the biodistribution of 111In-pentetreotide significantly. Whereas the radioactivity in liver, spleen and kidney decreased, hepatic metastases showed increased contrast. In one patient, liver metastases could only be detected during octreotide treatment. These data suggest that the diagnostic reliability of somatostatin receptor scintigraphy in carcinoid liver metastases is not necessarily compromised by octreotide therapy. Because of different biodistributions, the detection of liver metastases may even be improved during octreotide therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lamberts SWJ, Hofland LJ, v. Koetsveld PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localisation and therapy. J Clin Endocrinol Metab 1990;71:566–574.
Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991;12:450–482.
Bihl H, Sterz M, Mäcke H et al. Somatostatin receptor scintigraphy: a new scintigraphic tool in the management of intestinal carcinoids? In: Schmidt HAE, Höfer R, eds. Nuclear medicine, Stuttgart New York: F.K. Schattauer; 1992.
Dörr U, Räth U, Schürmann G, Höring E, Bach D, Wurm K, Scholz M, Adrian HJ, Bihl H. Somatostatin-Rezeptor-Szinti graphie — ein neues bildgebendes Verfahren zum spezifischenil Nachweis von Dünndarmkarzinoiden. Fortschr Röntgenstr 1993;158:67–73.
Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs. Metabolism 1990;39 Suppl 2:152–155.
Bakker WH, Krenning EP, Reubi JC, Breeman WAP, Setyono-Han B, de Jong M, Kooij PPM, Bruns C, van Hagen PM, Marbach P, Visser TJ, Pless J, Lamberts SWJ. In vivo application, of [111In-DTPA-d-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 1991;49:1593–1601.
Author information
Authors and Affiliations
Additional information
Correspondence to: U. Dörr
Rights and permissions
About this article
Cite this article
Dörr, U., Räth, U., Sautter-Bihl, ML. et al. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med 20, 431–433 (1993). https://doi.org/10.1007/BF00209003
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00209003